FDA Approved: NINLARO — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved NINLARO (ixazomib) in its original application from Takeda Pharmaceuticals America, Inc. for the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

ORIG AP for NINLARO (IXAZOMIB)